PhaseBio Pharmaceuticals, Inc. filed a notice of extension of certain bidding dates in the US Bankruptcy Court on December 22, 2022. As per the notice filed, with respect to Non-Bentracimab Assets, bid deadline is extended till January 6, 2023, auction shall be held on January 17, 2023, sale hearing shall be held on January 30, 2023 and sale closing shall occur on or prior to February 3, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% | 0.00% | 0.00% |
1st Jan change | Capi. | |
---|---|---|
0.00% | 49 | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- PHAS.Q Stock
- News PhaseBio Pharmaceuticals, Inc.
- Notice of Rescheduled Auction Filed by PhaseBio Pharmaceuticals, Inc.